五洲医疗（301234）披露2025年度业绩预告，1月29日股价下跌0.54%

Core Viewpoint - Wuzhou Medical (301234) is expected to report a significant decline in net profit for the fiscal year 2025, with projections indicating a drop of 47.46% to 59.97% compared to the previous year [1] Group 1: Stock Performance - As of January 29, 2026, Wuzhou Medical's stock closed at 40.38 yuan, down 0.54% from the previous trading day [1] - The stock opened at 40.9 yuan, reached a high of 41.2 yuan, and a low of 40.2 yuan, with a trading volume of 28.97 million yuan and a turnover rate of 1.05% [1] Group 2: Financial Forecast - The company forecasts a net profit attributable to shareholders of between 16 million yuan and 21 million yuan for 2025 [1] - The net profit after deducting non-recurring gains and losses is expected to be between 11 million yuan and 16 million yuan, representing a year-on-year decline of 54.98% to 69.05% [1] - The decline in performance is attributed to reduced operating income, falling product prices, and increased exchange losses due to currency fluctuations [1]